Forum: AMT Holding » Listing Amsterdam Molecular Therapeutics terminates and company and its shares cease to exist

Met IEX wordt u een betere belegger en verhoogt u het rendement op uw beleggingen

Vanaf 13,95 per maand leest u dagelijks onze professionele aandelenanalyses en kooptips.

Krijg toegang tot vele voordelen

Onbeperkt toegang tot onze Premium-content
Ons magazine IEX Expert (digitaal of papier)
Toegang tot onze 3 modelportefeuilles

Profiteer van de IEX producten

3 Modelportefeuilles
Dividendkalender
Aandelenselector

flosz 16 november 2012 13:37

Listing Amsterdam Molecular Therapeutics terminates and company and its shares cease to exist

Nov 16, 2012
Listing Amsterdam Molecular Therapeutics terminates and company and its shares cease to exist

Amsterdam, The Netherlands – November 16, 2012 – Amsterdam Molecular Therapeutics (AMT) Holding NV in liquidation (in liquidatie) (Euronext: AMT) announces that during the action period (verzetsperiode) no action (verzet) was instituted against the account and justification (rekening en verantwoording) as prepared and made available for inspection by the liquidators.
In accordance with previous announcements, as of 19 November 2012, AMT's shares will be delisted from NYSE Euronext in Amsterdam, with 16 November 2012 being the last trading date. On 19 November 2012, AMT's liquidation shall be finalised and the legal entity AMT shall cease to exist. As a consequence of AMT ceasing to exist, all AMT shares shall also cease to exist on 19 November 2012, without any (further) distribution or compensation to their holders. AMT shareholders that hold their AMT shares in book entry form will have their position in AMT shares in their securities account struck and deleted as per 19 November 2012. To the extent that AMT shares still may appear in your securities account after 19 November 2012, this will be for administrative purposes only, as the AMT shares proper shall then no longer exist.
On March 30, 2012, an extraordinary general meeting of shareholders approved a major corporate restructuring and financing transaction involving the disposal of the Group's entire business and operations to uniQure B.V. and the subsequent dissolution, liquidation and delisting of AMT (in liquidation).
www.amtbiopharma.com/news/159/182/Lis...

www.youtube.com/watch?v=IM39yIKoSo4

Direct naar Forum

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

AEX	860,75	-0,53%
EUR/USD	1,0665	+0,21%
FTSE 100	7.848,93	-0,36%
Germany40^	17.756,10	-0,46%
Gold spot	2.380,53	+0,05%
NY-Nasdaq Composite	15.601,50	-0,52%

Econoc...	+0,12 +5,50% 0.12 5.5046
WDP	+0,74 +2,96% 0.74 2.9624
AB InBev	+0,80 +1,48% 0.8 1.4771
Aedifica	+0,60 +1,04% 0.6 1.039
Colruyt	+0,40 +0,98% 0.4 0.9761

Barco	-0,29 -1,91% -0.29 -1.9079
Kinepolis	-0,75 -1,84% -0.75 -1.8382
Deceun...	-0,04 -1,78% -0.045 -1.7751
DEME G...	-2,40 -1,66% -2.4 -1.6598
Recticel	-0,18 -1,51% -0.18 -1.5126

Beurscodes, betekenis en hulp bij zoeken

Europa

Noord-Amerika

Kunt u een instrument niet vinden?

Waar vind ik die ISIN code?

Inloggen

Met IEX wordt u een betere belegger en verhoogt u het rendement op uw beleggingen

Krijg toegang tot vele voordelen

Profiteer van de IEX producten

Nederland

Europa

Amerika

AMT Holding« Terug naar discussie overzicht

Listing Amsterdam Molecular Therapeutics terminates and company and its shares cease to exist

flosz

Aanbevelingen

Aantal posts: 7.005

Meedoen aan de discussie?

Direct naar Forum

Indices

Stijgers

Dalers

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links

Pearl Capital: beleggen met zekerheid

Nederlandse MKB Participatiemaatschappij

Bitvavo

Hét Warren Buffett-pakket al aangevraagd?

Meld u aan voor de dagelijkse Beursupdate

Verzoek